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http://dx.doi.org/10.1016/j.jaci.2017.05.010allergen, and air pollution exposures. The abundance and
diversity of microbial exposures during the first months and
years of life have been linked with risk of allergic sensitization
and disease. Indoor environmental allergen exposure during
early life can also affect disease development, depending on the
allergen type, dose, and timing of exposure. Recent evidence
supports the role of ambient air pollution in allergic disease
inception. The lack of clarity in the literature surrounding the
relationship between environment and atopy reflects the
complex interplay between cumulative environmental factors
and genetic susceptibility, such that no one factor dictates
disease development in all subjects. Understanding the effect of
the summation of environmental exposures throughout a child’s
development is needed to identify cost-effective interventions
that reduce atopy risk in children. (J Allergy Clin Immunol
2017;140:1-12.)
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Like many chronic health conditions, allergic disease likely
results from complex gene-environment interactions. Mapping of
the human genome has advanced our understanding of genetic
risk factors for allergic diseases. However, the increase in the1
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occurred too rapidly to be accounted for by changes in the genome
alone and is more likely to be the result of changes in
environmental factors that are in some cases accompanied by
epigenetic changes. These observations have led to increasing
interest in understanding the effect of the exposome on the
development of atopic disease. In 2005, Christopher Wild framed
our understanding of the exposome concept to include 3 types of
exposures: (1) the general external environment, including factors
such as urban-rural residence, climate, air pollution, social
capital, and education; (2) one’s specific external environment,
including diet, physical activity, tobacco exposure, infection, and
occupation; and (3) the internal environment, which includes the
biological and metabolic/toxicological manifestations of these
exposures in the body.1 In this review we explore the effect of a
variety of environmental exposures in early life that have been
found to influence the development of allergic disease, with
particular focus on exposures to microbes, allergens, and ambient
air pollutants.MICROBIAL EXPOSURE
The increase in the prevalence of allergic disease, particularly
in the Western world, has coincided with significant environ-
mental changes that have reducedmicrobial exposure in early life,
such as improved sanitation and increased rates of immunization.
Many have proposed that among genetically susceptible subjects,
these changes in environmental conditions might alter normal
development of the immune system and thus affect susceptibility
to allergic disease, the basis of the hygiene hypothesis.2 In this
section we will discuss key findings from studies examining
both endogenous and exogenous microbial exposures.The host microbiome
The human microbiome consists of all microbial communities
within the body, including the gut, airways, skin, and others.
Alteration of the host microbiome is suspected to play a role in
susceptibility to allergic disease, particularly during early life,
coinciding with maturation of the immune system. Establishment
of the microbiome begins in utero and is likely the result of
maternal transmission.3-5 During infancy, differences in the gut
microbial environment between those who go on to have atopy
and those who do not are apparent in the first few months of
life. Reduced diversity of stool flora at age 1month was predictive
of atopic eczema at age 2 years and allergic sensitization and
allergic rhinitis at age 6 years.6
Similarly, diversity of microbial species in the infant gut was
shown to be inversely related to risk of atopic sensitization,
allergic rhinitis, and eosinophilia.7 Atopic children showed
reduced early life colonization with Lactobacillus species,8
Bifidobacterium species,8,9 andBacteroides species and increased
colonization with Clostridia species8 and yeasts.9 A greater
abundance of Bacteroides and Lactobacillus species has been
associated with protection against allergy, whereas abundance
of Clostridia species has been associated with wheezing, allergic
sensitization, and atopic eczema.10,11
Microbial colonization of the airways also begins early in life.
Colonization with Streptococcus species at age 2 months was
associated with increased risk for earlier first lower respiratorytract illness, which has been linked to later asthma development.12
Similarly, in a study from the Copenhagen Prospective Studies on
Asthma in Childhood birth cohort, asymptomatic 1-month-old
neonates colonized with Streptococcus pneumoniae, Moraxella
catarrhalis, or Haemophilus influenzae through hypopharyngeal
aspirate were at greater risk of a first wheezing episode, persistent
wheeze, severe exacerbation of wheeze, and hospitalization for
wheeze.13 Lower airway colonization with these organisms was
also associated with higher blood eosinophil counts and total
IgE levels but not specific IgE levels at 4 years and with
bronchodilator reversibility and development of asthma at age
5 years. In a study of children younger than 3 years hospitalized
for virus-induced wheezing, 60% demonstrated nasopharyngeal
colonization with Streptococcus pneumoniae, Moraxella
catarrhalis, or Haemophilus influenzae, and this was associated
with increased risk of recurrent wheezing episodes during the
following year.14 Importantly, antibiotic usemight select for these
organisms.12
Many factors can affect microbial colonization in infants and
young children, including prenatal and postnatal antibiotic
exposure, mode of delivery, and early diet. Wu et al15 identified
dose-dependent relationships between risk of childhood asthma
and maternal urinary tract infections during pregnancy or infant
antibiotic use during the first year of life. The increase in risk is
presumably due to changes in the abundance and diversity of
the host’s commensal microbes, as demonstrated by Penders
et al,16 who reported that antibiotic use in infancy was associated
with decreased abundance of Bifidobacterium and Bacteroides
species.
Mode of delivery is also an important determinant of the infant
microbiome,17 although the effect of vaginal versus caesarean
delivery on development of allergic disease is debated.
Vaginally delivered infants tended to be colonized with vaginal
(Lactobacillus species) and fecal (Prevotella species) flora,
whereas infants born by means of caesarean section tended to
be colonized by skin flora (Staphylococcus and Corynebacterium
species),17 with increased abundance of Clostridium difficile
and reduced Bifidobacterium and Bacteroides species.16
Meta-analyses of studies examining the association between
delivery mode and allergic disease in Western countries found
an increased risk of childhood asthma,18,19 allergic rhinitis,18
and food allergy18 in children born by means of caesarean section
compared with vaginal births. However, studies from outside the
United States and Europe have not consistently shown these
effects.20-22
Diet during early life can also be important for establishing the
infant’s microbiome. Breast-feeding was associated with greater
microbial diversity compared with formula feeding,23 and a
recent study reported that breast-feeding was associated with a
trend toward increased Bifidobacterium and reduced Clostridia
species at 3 to 6 months of age.24
Despite this evidence, it remains unclear whether these
differences in the infant microbiome promote development of
allergy or merely serve as a marker of immune dysregulation
early in life that leads to allergic disease.The external microbial environment
Exposure to abundant and diverse microbes in the environment
appears to augment the risk of allergic disease. The ‘‘biodiversity
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the rich environmental microbiome inherent within natural green
spaces impedes cultivation of a robust host microbial community,
leading to immune dysregulation, although the exact mechanisms
of this interplay are unknown.25 To this effect, Ruokolainen et al26
demonstrated that children living in homes surrounded by
forests and agricultural land had lower rates of aeroallergen
sensitization compared with their counterparts in industrialized
environments.
In addition to environmental biodiversity, specific microbial
products have been identified as key players in immune tolerance.
Endotoxin, a component of gram-negative bacterial cell walls and
a marker of microbial exposure, was among the first microbial
products implicated in protection against atopic asthma and other
allergic diseases.27-30 The Allergy and Endotoxin cross-sectional
survey found that higher levels of endotoxin in child
mattresses were associated with reduced risk of allergic
sensitization, hay fever symptoms, and atopic asthma.27 The
precise mechanism for this effect is not known. One theory
suggests that increased exposure to environmental endotoxin
leads to downregulation of inflammatory responses.27
Others have suggested the protective effect is the result of
polymorphisms within the CD14 gene, which encodes a
coreceptor for Toll-like receptor 4 with high specificity for LPS,
and in fact, a recent systematic review found a significant
gene-environment interaction between CD14 polymorphisms
and microbial exposure.31 The timing of endotoxin exposure
also appears to be important, with more significant protective
effects seen with early-life exposure.28,32
The microbial environment within the home is dictated by its
human and nonhuman occupants. For instance, homes with dogs
contain richer and more diverse bacterial communities compared
with homes without pets.33 Differences in microbial exposure are
seen with increasing family size,15 as well as with certain
activities of the occupants, particularly farming. It has long
been recognized that the prevalence of allergic disease among
the children of farmers is lower than in nonfarming
families.28,34-36 A number of studies have been conducted to
identify farm-specific factors, such as consumption of raw
milk37-40 and exposure to high amounts of endotoxin in animal
stables, that influence inception of allergic disease.
A recently published study compared the incidence of allergic
disease in children from an Amish traditional farming commu-
nity with those from a Hutterite community that, although
genetically similar to the Amish, practices modern industrial
farming. The authors reported a significantly lower prevalence
of allergic disease in Amish children. Amish homes were found
to contain higher levels of endotoxin in airborne house dust, and
comparisons of bacteria isolated from mattress dust showed
distinct microbial profiles between Amish and Hutterite
households. To further examine the effects of the Amish
environment on allergy, the authors administered Amish house
dust intranasally to ovalbumin (OVA)–sensitized mice and
demonstrated reduced airway hyperresponsiveness and
bronchoalveolar lavage eosinophilia in response to OVA
challenge. Conversely, intranasal administration of Hutterite
house dust led to exacerbation of OVA-induced airway
hyperresponsiveness and eosinophilia. Although the precise
components responsible for this protective effect are unknown,
the inhibitory effects of Amish house dust for OVA-mediatedinflammation were reduced in mice deficient in myeloid
differentiation response gene–88 and TIR-domain-containing
adapter-inducing interferon-b (TRIF), suggesting the protective
effects were primarily mediated by the innate immune
response.41Role of childhood respiratory tract infections
For asthma development in particular, there is abundant
literature suggesting a critical role for viral respiratory tract
infection in early life. Respiratory syncytial virus (RSV) and
human rhinovirus (HRV) are most frequently associated with
wheezing episodes in young children.42-44 In the prospective
cohort RSV Bronchiolitis in Early Life study, approximately
50% of the 206 infants with lower respiratory tract illness caused
by RSV during the first 12 months of life subsequently had
persistent asthma up to age 7 years.45 Similarly, in a
case-control study of infants hospitalized with RSV versus
healthy control subjects followed to age 18 years, a significantly
higher prevalence of current asthma was seen in the RSV group
compared with the control group; RSV was the major risk factor
in subsequent asthma development (odds ratio, 7.2; 95% CI,
2.1-23.9).43
Others have found that HRVinfection might be equally or more
important for development of asthma than RSV. Asthma
development by school age was 4 times greater in wheezing
infants with HRV infection compared with the incidence in
infants with other viruses in one study.44 In the Childhood Origins
of Asthma (COAST) birth cohort, a group at high risk for devel-
opment of asthma, HRV-induced wheezing in infancy was the
strongest predictor of persistent wheezing at age 3 years and diag-
nosis of asthma at age 6 years.46,47
Prevention of viral infection in early life has been proposed as a
strategy for primary prevention of asthma, but thus far, this has not
been possible given the difficulties with synthesizing an effective
vaccine against HRV. A few trials have been conducted with
palivizumab, or RSV-specific IgG. Simoes et al48 reported a lower
incidence of recurrent wheezing in premature infants treated with
palivizumab compared with untreated control subjects. In a
randomized controlled trial Blanken et al49 found that premature
infants receiving palivizumab had fewer wheezing days during
the first year of life. Whether these effects would translate into
reduced incidence of asthma remains unknown.INDOOR ALLERGEN EXPOSURE
The indoor environmental allergen milieu is of particular
interest in the study of the determinants of allergic disease
because of constant exposure during early childhood and the
potential for intervention. In samples taken from 831 homes
across the United States, at least 6 detectable allergens were found
in more than 50% of homes.50 Allergens from house dust mite
(HDM), furred pets (cats and dogs), mice, cockroaches, and fungi
comprise the most common indoor allergens implicated in
patients with atopic disease.51-53 The strong relationship between
allergic sensitization and development of allergic rhinitis and
asthma has been well documented.53-57 Recently, Rubner et al54
demonstrated that aeroallergen sensitization before the age of
5 years significantly increased the risk of asthma with persistence
into adolescence. Although the role of allergen sensitization in the
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relationship between individual allergen exposure and the
development of these conditions has been more difficult to
delineate, likely because of the complexity of interactions
between various environmental factors, the timing and dose of
exposure, and genetic predisposition. Similarly, the direct effect
of indoor allergens on the development of atopic dermatitis
(AD) has not been clearly established, although the correlation
between indoor allergen sensitization and disease activity is better
understood.58-60 In turn, AD enhances the development of allergic
rhinitis and asthma by providing an epicutaneous route of
sensitization to aeroallergens through transepidermal water loss
and epidermal barrier dysfunction.61 In this section we briefly
discuss some of the existing literature surrounding each of the
indoor allergens and their role in allergic disease.HDM exposure
HDM allergen has long been implicated as an important
determinant of atopic disorders. An early prospective study by
Sporik et al62 followed 65 children from birth to age 11 years and
demonstrated increased risk of allergic sensitization and asthma
in children exposed to high levels of HDM during the first year
of life. Subsequently, similar studies have provided evidence for
a causal relationship between HDM sensitization early in life
and allergic rhinitis, persistent wheeze, and asthma.63-67
Although sensitization has a positive correlation with asthma
development, studies from European birth cohorts have
established that exposure to HDM alone is not sufficient to incur
an increased risk of asthma,68,69 indicating that IgE sensitization
is the bridge between allergen exposure and asthma development;
however, innate immune responses triggered by HDM have also
been implicated in allergic disease pathogenesis.70 Tovey et al71
suggest a nonlinear dose-response relationship between HDM
exposure and development of allergic disease, with exposure to
both very low and very high levels of allergen correlating with
decreased risk of sensitization and asthma and exposure to
intermediate levels of allergen correlating with increased risk.
Whether host or concomitant environmental factors alter the
otherwise positive association between HDM exposure and
atopy at these critically low and high levels remains unknown.
Exposure to intermediate concentrations of HDM allergen has
also been linked to atopic disease severity.72,73 More
recent studies have focused on differing routes of early HDM
exposure, such as placental and breast milk transfer, as additional
potential risk factors for development of allergic respiratory
disease.74,75Household pest exposure
In addition to HDM, exposure to mouse and cockroach
allergens has been linked to allergic disease prevalence and
severity, particularly in urban settings.76-86 In a prospective birth
cohort of 505 infants of atopic parents from the metropolitan
Boston area, Gold et al79 found that exposure to cockroach
allergen levels in the family room of greater than 0.05 U/g of
dust was an independent predictor for early wheeze. Evidence
for cockroach exposure as a risk factor for persistent wheeze
and asthma was provided by an evaluation of 222 siblings of
the above infants, with those exposed to higher concentrationsof allergen having the greatest risk.80 Data from the same Boston
cohort also illustrated an association between early mouse
allergen exposure and early wheeze82 and a nonstatistically
significant trend toward predicting asthma, allergic rhinitis, and
AD at 7 years of age.87 In a similar prospective study of infants
followed for 3 years, Donohue et al78 not only found a significant
effect of mouse and cockroach sensitization on the prevalence of
AD, allergic rhinitis, and asthma but also demonstrated a
dose-response relationship between higher cockroach or
mouse-specific IgE levels and increased prevalence of allergic
disease. Thus the evidence for mouse and cockroach allergen
exposure predicting the development of atopic disorders,
especially in inner-city children, is compelling.Furred pet exposure
In contrast, a plethora of contradictory associations exists
between furred pet exposure and development of atopy. Studies
examining the link between pet ownership and risk of atopic
disease have generally focused on the most common household
pets, cats and dogs, or examined pet keeping in general. The
ubiquitous nature of cat and dog allergens88-90 makes
epidemiologic studies assessing the risk of ‘‘exposure’’ quite
difficult. To this effect, Liccardi et al91 questioned whether
surveys regarding the presence of pets in the home or home
allergen measurements are sufficient to accurately convey a
subject’s exposure.
A number of systematic reviews examining the effect of pet
exposure on allergic disease have been conducted, a few of which
will be highlighted here. Takkouche et al92 reviewed cohort
studies from 1996-2007 that assessed pet allergen exposure.
Although dog exposure had no significant effect on asthma,
exposure to cat allergen yielded a relative risk for asthma of
0.72 (95% CI, 0.55-0.93); exposure to either pet was found to
be slightly protective for allergic rhinitis (relative risk, 0.79;
95% CI, 0.68-0.93). No associations between asthma and early
exposures to cat and dog allergens were found in 17 and 13 birth
cohorts included in a systematic review, respectively.93 Finally,
pooled analysis of data from 11 European birth cohorts found
no effect of early pet ownership on asthma development or
allergic rhinitis when examining mutually exclusive pet
ownership categories (cat only, dog only, cat and dog only, bird
only, or rodent only).94 Overall, the cumulative evidence suggests
no increase in risk of allergic disease from pet allergen exposure,
with a possible decreased risk of asthma associated with cat
allergen exposure in one study. More recent studies focus on
subgroup analyses, which might explain some of the variability
in results of existing data.95Indoor fungal exposure
Similar to pet allergens, fungi are ubiquitous in both indoor and
outdoor environments, and both predictive and protective
associations of indoor fungal exposure on atopic disorders have
been discovered. Qualitative assessments of fungal exposure in
the form of mildew odor or visible mold have been linked to
increased risk of allergic rhinitis and asthma.96-98 This finding is
corroborated by studies using quantitative fungal measures, such
as DNA-based analyses99 and b-1,3-glucan measurements.100,101
In a longitudinal birth cohort of high-risk infants, Iossifova
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to low levels ofb-1,3-glucan but a protective effect on exposure to
levels of b-1,3-glucan greater than 60 mg per gram of dust,
suggesting a possible nonlinear dose-response relationship
similar to that observed for HDM allergen. However, although
increased levels of b-1,3-glucan might indicate greater fungal
concentrations, it could also represent a more diverse fungal
population. In fact, exposure to greater fungal diversity offered
protection against sensitization to aeroallergens and early
childhood wheeze in a German longitudinal birth cohort,
mirroring the protective effects of microbial diversity in the
human microbiome.102 Importantly, the predictive effect of
fungal exposure on asthma development seems to occur
independently of fungal sensitization. Zhang et al103
demonstrated that nonallergenic components of fungi promote
TH17 responses through direct activation of innate immune
receptors. Fungal components also potentiate allergen-induced
TH2 responses through non–IgE-mediated pathways. The
mechanism by which greater fungal diversity confers protection
against allergic disease remains unclear.
Overall, convincing data exist for the role of environmental
indoor allergens in the pathogenesis of allergic disorders. The
positive effect of multifaceted environmental interventions on
disease prevalence and morbidity104,105 highlights this point.
Further studies are needed that examine the complex interplay
of environment and genetics to determine the most effective
intervention strategies for reducing the risk of allergic disease.AMBIENT AIR POLLUTION EXPOSURE
Great strides have been made in understanding the effects of
environmental air pollutants on population health, which has
affected environmental health policy and consequently improved
public health. However, despite overall improvements in air
quality, indoor and outdoor air pollutants continue to cause
adverse health effects and have been shown recently to promote
the onset of atopic disease.
The World Health Organization reported in 2016 that 92% of
the world’s population lives in places where air quality levels
exceed the World Health Organization’s ambient air quality
guidelines for annual mean particulate matter (PM) with a
diameter of less than 2.5 mm (PM2.5).
106 Those thought to be
especially susceptible to the effects of air pollution include the
very young and those of lower socioeconomic status because of
increased exposure to pollutants in poor housing conditions.
The respiratory tract is particularly susceptible to air pollution
because of continuous exposure to the ambient environment. In
this section we will discuss the effects of 2 key sources of
environmental air pollution, traffic-related air pollution (TRAP)
and environmental tobacco smoke (ETS), on the development
of allergic airway disease. Markers of TRAP include (but are
not limited to) carbon monoxide, nitrogen oxides, black carbon,
PM, benzene, and ultrafine particles.Effects of TRAP on lung development and asthma
risk
Numerous studies throughout theworld have shown that TRAP
(particularly PM2.5) negatively affects lung development
107-109
with potential consequences for the development of asthmaand chronic obstructive pulmonary disease. The effects of
early-life exposure, both prenatal and postnatal, are of particular
interest in efforts to prevent detrimental effects on lung
development.
The Spanish Infancia y Medio Ambiente cohort examined the
association of TRAP exposure during specific trimesters of
pregnancy on lung function in children aged 4.5 years.110
Exposure to higher levels of benzene and nitrogen dioxide
(NO2) during the second trimester of pregnancy was associated
with increased risk of clinically significant low lung function
(FEV1 <80% of predicted value). These studies collectively
demonstrate that exposure to air pollution has systemic
implications, with significant consequences for fetal lung
development. Efforts to promote prevention focus on examination
of prenatal exposures on asthma development. The Asthma
Coalition on Community, Environment and Social Stress project,
an urban pregnancy cohort, found that prenatal exposures to black
carbon and PM were associated with a significant risk of
wheezing by age 2 years.111 Moreover, exposure to increased
PM2.5 levels during the second trimester of pregnancy was
significantly associated with asthma at age 6 years, particularly
in boys.112
Postnatal exposure to TRAP, particularly during the first
years of life, is also an important determinant of lung function
and asthma development. A birth cohort from the Boston
metropolitan area recruited between 1999 and 2002
demonstrated that TRAP was associated with reduced lung
development in elementary school–aged children, as measured
by means of spirometry.113 Despite improvements in PM2.5
levels (less than current US Environmental Protection Agency
standards) for most of the cohort during the study, lifetime and
prior year exposure to TRAP was associated with a reduction
in forced vital capacity, and exposure to PM2.5 was specifically
associated with higher odds of clinically significant airway
obstruction. A Swedish birth cohort examined the effect of
TRAP during the first year of life on lung function in later
childhood.114,115 At age 8 years, exposure to PM measuring
between 2.5 and 10 mm in diameter during the first year of
life had a bigger effect on reduced FEV1 in children sensitized
to food and aeroallergens, with less effect on lung function if
exposure occurred later in childhood. Additionally, high
exposure to NO2 during the first year of life was associated
with increased odds of having significantly decreased FEV1
and forced vital capacity values.
Although many studies have demonstrated an association
between early-life exposure to pollutants and asthma or persistent
wheezing,116-123 conflicting evidence recently emerged from a
cross-sectional examination of 5 European birth cohorts in which
no associations were found between air pollutant exposure and
asthma prevalence.124 To further examine these discrepancies, a
recent longitudinal examination using birth cohort data from
more than 14,000 children from The Netherlands, Germany,
and Sweden evaluated the relationship of annual air pollution
concentrations (from birth through age 14-16 years) with asthma
and rhinoconjunctivitis incidence and prevalence.125 This study,
using both meta-analyses and pooled analyses, found that
increasing exposure to NO2 and PM2.5 at the birth address was
associated with increased asthma incidence through adolescence.
There was no effect of air pollutants on rhinoconjunctivitis. Other
European and North American cohorts have shown that increased
FIG 1. Interplay of early-life exposures that affect allergic disease development. Allergic disease
development is influenced by many different factors. This figure displays several of the identified
environmental triggers that increase susceptibility to allergic disease. A, Common behaviors and
determinants that influence a subject’s microbiome and external microbial environment, thereby
influencing susceptibility to allergic disease. B, Allergens that have been linked to development of atopy.
C, Air pollution exposures that not only influence lung function but also contribute to the immune response.
Collectively, this Venn diagram demonstrates the overlapping contributions of each exposure. The center of
the figure shows the questions that have yet to be elucidated, including how any of the numerous
combinations of these common exposures influence the onset of disease or affect disease severity.
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with increased risk of asthma at age 12 years.126Effects of ETS on asthma and allergy risk
However, the most profound prenatal and early-life in-
fluences of air pollution emerge from ETS. Despite greatimprovements in reducing the rate of smoking and second-
hand smoke (SHS) exposure in the US population, approxi-
mately 25% of nonsmokers in the United States (58 million
people) were still exposed to SHS in 2011-2012.127 Of these,
15 million were children aged 3 to 11 years. ETS exposure
has been identified as a major risk factor for asthma128,129
and allergic sensitization,130 especially with in utero or
TABLE I. Early-life exposures affecting allergic disease development
Protective against allergic disease References Promoting allergic disease References
Vaginal birth 16-19 Prenatal/postnatal antibiotics 15,16
Increased microbial/fungal diversity 6-11, 23-26, 102 Viral lower respiratory tract infection (RSV, HRV) 42-47
Increased no. of siblings; later birth order 15 HDM, cockroach, mouse, and fungal exposure 62-67, 71-86, 96-101
Farm exposure 28, 34-40 Prenatal/postnatal exposure to air pollution 110-123, 125,126, 133-136
Endotoxin exposure 27-33 Prenatal/postnatal tobacco smoke exposure 131, 132, 138-140
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to SHS have more recently been elucidated. Pooled analyses
from 15 European birth cohorts found that children whose
mothers were exposed to SHS during pregnancy were more
likely to wheeze at age 2 years; this risk was further
increased by postnatal SHS exposure and further increased
in children of atopic families.131 SHS exposure during preg-
nancy alone (in nonsmoking mothers) was recently found to
be associated with physician-diagnosed asthma at age
7 years.132 With the increasing popularity of e-cigarettes
throughout the world, it will be imperative to examine the ef-
fects of vaporized nicotine, vehicles (eg, propylene glycol),
and an endless variety of flavoring agents on the development
of asthma and airway disease.Pollutants and allergen sensitization
A Swedish birth cohort133 found that high exposure to
NO2 during the first year of life was associated with
increased risk of sensitization to pollens (assessed by means
of blood IgE measurement) at age 4 years and food sensiti-
zation at age 8 years. In North American cohorts diesel
exhaust particle exposure in the first year of life was associ-
ated with greater aeroallergen sensitization in early childhood
than in children with low exposure.134,135 Children who were
aeroallergen sensitized and had high exposure to TRAP dur-
ing the first year of life had an almost 3-fold higher risk of
asthma development compared with children who were not
sensitized to allergens,135 nor did sensitization alone increase
the risk of asthma in children exposed to low levels of
TRAP, suggesting that the combination of early-life pollutant
exposure and allergic sensitization contributes to asthma
development.
Exposure to increased levels of TRAP during infancy has also
been associated with atopy to foods and perennial aeroallergens at
age 1 year.136 These effects might extend to the prenatal period.
The EDEN birth cohort study found that increasedmaternal expo-
sure to PM measuring between 2.5 and 10 mm in
diameter was associated with reduced numbers of infant
regulatory T (Treg) cells and increased CD81 T-cell numbers
at birth,137 with potential to increase the risk of atopy
development and/or affecting responses to viral infection in these
infants.
The strongest links between pollutant exposure and allergic
sensitization relate to ETS exposure. In the absence of
maternal smoking, exposure to SHS in infancy was associated
with an increased risk of food sensitization at age 4, 8, and
16 years138 and an increased risk of eczema with allergic
sensitization. The German Lifestyle and EnvironmentalFactors and their Influence on Newborns Allergy risk birth
cohort found that increased exposure to products of ETS dur-
ing pregnancy was associated with increased eosinophil/baso-
phil progenitor cell counts in cord blood and that cord blood
IL-4 and IL-13 levels were associated with the development
of these progenitor cells.139 This group later described that
maternal smoking or ETS exposure during pregnancy was
associated with reduced numbers of infant Treg cells at birth
and that these infants with reduced numbers of Treg cells had
increased risk of allergic sensitization in the first year of
life.140Potential mechanisms for effects of air pollution on
development of atopic disease
Recent mechanistic studies investigating the effect of
pollutant exposure on the development of allergic disease
have been guided by key findings from birth cohorts,
including the role of oxidative stress on promoting epigenetic
modifications that regulate gene expression of Treg cells
through microRNAs (miRNAs) and DNA methylation.129,141
miRNAs are small noncoding RNAs that repress target pro-
tein expression through numerous mechanisms, including de-
stabilizing mRNA and translational silencing.142 ETS
exposure during pregnancy was associated with increased
maternal and cord blood expression of miRNA-223,143 an
miRNA previously linked with Treg cell development and
function.144-146 Increased miRNA-223 expression was associ-
ated with reduced Treg cell numbers in maternal and cord
blood; in turn, these reduced Treg cell numbers at birth
were associated with increased risk of AD during the first
3 years of life.
Among the most common mechanisms for epigenetic
modifications is DNA methylation, in which increased
methylation at the promoter and the 39 end silences a gene,
negatively correlating with gene expression. Increased forkhead
box P3 methylation from salivary DNA was associated with
increased pollutant exposure during childhood, affecting both
increased risk of asthma diagnosis at age 7 years147 and asthma
severity.148 Although pollutant-induced epigenetic modifications
are not restricted to Treg cell development and function, their
dysregulation has potential to affect the development of allergic
disease over the lifespan.149CONCLUSIONS AND FUTURE DIRECTIONS
The effect of microbial, allergen, and air pollutant expo-
sures has been artificially subdivided in this review; in reality,
these exposures and many others interact simultaneously with
FIG 2. Potential interventions reducing the risk of allergic disease
development. A, Certain modifications can positively influence a subject’s
microbiome or select for a protective external microbial environment.
B, Reducing the quantity of allergen exposure might reduce development
of allergic disease. C, Although the highest pollutant exposures occur
from exposure to ETS, mitigating industrial and TRAP exposures will
have to come from national and local regulatory agencies throughout the
world. The center of the figure highlights the questions that have yet to
be elucidated. Could these interventions affect the incidence of allergic dis-
ease, and if so, which are the most pragmatic and cost-effective and have
the highest potential effect in different societies? C-section, Caesarian
section.
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example, air pollution and climate change can promote oxida-
tive stress in pollen-producing plants, increasing both the
amounts and allergenicity of pollen grains.150 Individual fac-
tors identified in this review as protective for or promoting
the development of atopy are summarized in Table I.* The
types of exposures explored here are in no way exhaustive
because many other exposures in early life have been linked
to allergy and asthma development, including diet, obesity,
pharmaceuticals, lifestyle factors, and maternal psychological
stress in the prenatal and postnatal period. For example,
vitamin D deficiency in the first decade of life was recently
associated with increased susceptibility to sensitization and
AD by age 3 years and increased risk of persistent asthma
by age 10 years.151 Additionally, the effect of maternal psy-
chological stress on atopic disease development is being*References 6-11, 15-19, 23-40, 42-47, 62-67, 71-86, 96-102, 110-123, 125, 126,
131-136, and 138-140.pursued by the South Korean Cohort for Childhood Origin
of Asthma and Allergic Diseases, who recently demonstrated
that increased prenatal maternal depression or anxiety was
associated with increased risk of infant AD by age
6 months.152
Because human subjects do not develop in exposure silos,
future studies should focus on identifying the effect of the
summation of these exposures with different degrees of
interaction among them in addition to the epigenetic effects of
these exposures. This approach can more effectively identify the
interventions that will have the greatest effect, both at the
legislative and individual levels, on the development and sequelae
of atopic disease. Examples of proposed interventions to date are
provided in Fig 2. Several research initiatives focused on the
exposome are being pursued in Europe (EXPOsOMICS, HELIX,
and Heals) and the United States (Hercules) to simultaneously
assess a large set of exposures while linking these exposures
with the body’s response through -omics approaches. These
investments might identify atopy risk factors that are
underestimated or perhaps yet undiscovered. Use of
environment-wide association study approaches to identify
associations with adverse health effects will bring their own
challenges, highlighted by recent publications noting that some
exposures might be highly correlated among each other and
some might be synergistic to promote adverse health effects.153
Additionally, it will be challenging to identify the effect of an
early-life exposure on the sensitivity to future exposures over
the lifespan. Exposome-focused projects are inherently expensive
at this time given the large sample sizes required to assess
numerous exposures in addition to the use of numerous tools
required to assess both external and internal exposome compo-
nents, including use of environmental monitoring technology
(by using both geographic information system-based pollutant
models and personal sensors) and -omics technologies. The cost
and efficiency of applying an exposome-focused approach to hu-
man disease will have to be improved to make discoveries with
the highest effect.
In the interim, integrating data from numerous birth cohort
studies throughout the world will aide in more clearly
defining the environmental determinants driving atopy and
perhaps elucidate the optimal time to implement interventions.
The Mechanisms of the Development of Allergy study
incorporated data from more than 44,000 European children
participating in birth cohort studies, and the Environmental
Influences on Child Health Outcomes program in the United
States includes more than 50,000 children. Large-scale birth
cohort studies with harmonized exposure and outcome
assessments throughout the world will need to be pursued
as we define the peak susceptibility periods to a variety of
exposures during the prenatal and postnatal periods and which
exposures relevant to specific geographic areas should be the
primary targets for interventions. An important example of
harmonized outcome assessments is clearly delineating be-
tween allergic versus nonallergic asthma when assessing the
effect of various exposures on this outcome. Once key
exposures and potential interventions are identified, an
integrative approach among clinicians, children and their
caregivers, health care organizations, insurance providers,
government agencies, and urban planners must be undertaken
to establish cost-effective primary and secondary prevention
strategies to reduce these risks and promote wellness.
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d The microbiome differs between atopic and nonatopic
subjects, and these differences are seen in the first few
months of life.
d Children exposed to farms and biodiversity in green
spaces during early life are at reduced risk of allergic dis-
ease, whereas early-life exposure to HDM, cockroach,
mice, and fungi promotes development of allergic disease.
d Wheezing episodes associated with RSV and HRV infec-
tion increase the risk of asthma in later childhood.
d There is no clear evidence that cat or dog exposure pro-
motes or prevents atopy development.
d Prenatal and early-life exposure to both indoor and out-
door air pollutants negatively affects lung development
and increases the risk of wheezing and asthma.
d Maternal smoking or exposure to SHS increases the risk
of asthma, allergic sensitization, and AD.
What is still unknown?
d Does alteration of the diversity and abundance of
commensal microbes in early life directly affect the devel-
opment of allergic disease, or are these differences merely
markers of immune dysregulation?
d What are the mechanisms by which early-life farm expo-
sure imparts protection against allergic disease?
d Can asthma development be prevented by RSV and/or
HRV immunization?
d What air quality standards are sufficient to prevent detri-
mental effects on lung development and atopic disease in
children?
d When are children most susceptible to the effects of air
pollution (prenatal, first year of life, or cumulative life-
time exposure), and what personalized interventions can
be developed to reduce the risks associated with pollution
exposure?
d What are the most cost-effective environmental interven-
tion strategies to prevent allergic disease, and how do
these strategies vary geographically?
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